DC Investments Management’s Thermo Fisher Scientific TMO Stock Holding History

DC Investments Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,727	Closed	-$626K	–	274
2020 Q2	$626K	Buy	1,727 +96	+6%	+$32.2K	0.23%	57
2020 Q1	$463K	Sell	1,631 -304	-16%	-$95.9K	0.38%	84
2019 Q4	$629K	Sell	1,935 -87	-4%	-$26.4K	0.48%	38
2019 Q3	$589K	Sell	2,022 -218	-10%	-$62.4K	0.34%	63
2019 Q2	$658K	Buy	2,240 +796	+55%	+$219K	0.37%	47
2019 Q1	$395K	Hold	1,444	–	–	0.25%	181
2018 Q4	$323K	Buy	+1,444	New	+$339K	0.26%	190
2018 Q3	–	Sell	-1,899	Closed	-$393K	–	315
2018 Q2	$393K	Sell	1,899 -5,886	-76%	-$1.25M	0.25%	254
2018 Q1	$1.61M	Sell	7,785 -2,868	-27%	-$602K	1.08%	11
2017 Q4	$2.02M	Buy	+10,653	New	+$2.04M	0.83%	5

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DC Investments Management's TMO Position: Q3 2020 in Review

DC Investments Management sold out of Thermo Fisher Scientific (TMO) in Q3 2020, closing a stake of 1,727 shares — an estimated $626K sold.

DC Investments Management first reported a position in TMO in Q4 2017 and held it in 10 quarters. The position peaked at $2.02M in Q4 2017. 1,848 funds tracked by Wall St. Rank hold TMO as of Q3 2020.

DC Investments Management reported no remaining Thermo Fisher Scientific position as of Q3 2020 after selling out during the quarter.
DC Investments Management sold 1,727 Thermo Fisher Scientific shares in Q3 2020, an estimated $626K.
DC Investments Management first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 10 quarters.
DC Investments Management's Thermo Fisher Scientific position peaked at $2.02M in Q4 2017.
1,848 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2020.

Based on DC Investments Management's 13F filing for Q3 2020, filed 4 Nov 2020.